Patent ID: 8067228
Filing Date: 2011-11-29
Classification: A61K,A61P,C07K,C12N

Abstract:
1. A pharmaceutical composition containing as active ingredient at least two nucleotide sequences coding for separate peptides chosen from A to D peptides, placed under the control of elements necessary for expression of nucleic acid sequences, in combination with a pharmaceutically appropriate vehicle, wherein the A peptide has at least the following amino acid sequence SEQ ID NO: 1: and has at most the 46 amino acids as defined in the following sequence SEQ ID NO:2: wherein the B peptide has at least the following amino acid sequence SEQ ID NO: 45: and has at most the 63 amino acids as described in the following sequence SEQ ID NO:46: wherein the C peptide has at least the following amino acid sequence SEQ ID NO: 127: and has at most the 57 amino acids as described in the following sequence SEQ ID NO:128: wherein the D peptide has at least the following amino acid sequence SEQ ID NO: 174: and has at most the 44 amino acids as defined in the following sequence ID NO:175: